Patrik Nikolić is a medicinal chemist who is working as a translational research scientist at RxTx and a life science and in vitro diagnostics sales and application specialist at Biomedica. His research work is in the field of computational biochemistry, working with tools such as RDKit, RxDock, GROMACS, and PyMOL.

In November 2021, Patrik published a paper titled Structure-based Molecular Docking in the Identification of Novel Inhibitors Targeting SARS-CoV-2 Main Protease (doi:10.23919/MIPRO52101.2021.9596660) in collaboration with Dr. Vedran Miletić and Dominik Kinkela from Group for Applications and Services on Exascale Research Infrastructure (GASERI) at Department of Informatics, University of Rijeka.

See his résumé for further information.